Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

425 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytokine blockers in psoriatic arthritis.
Mease PJ. Mease PJ. Ann Rheum Dis. 2001 Nov;60 Suppl 3(Suppl 3):iii37-40. doi: 10.1136/ard.60.90003.iii37. Ann Rheum Dis. 2001. PMID: 11890650 Free PMC article. Clinical Trial.
OMERACT 7 psoriatic arthritis workshop: synopsis.
Gladman DD, Strand V, Mease PJ, Antoni C, Nash P, Kavanaugh A. Gladman DD, et al. Among authors: mease pj. Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii115-6. doi: 10.1136/ard.2004.032615. Ann Rheum Dis. 2005. PMID: 15708925 Free PMC article. Review.
Psoriatic arthritis assessment tools in clinical trials.
Mease PJ, Antoni CE, Gladman DD, Taylor WJ. Mease PJ, et al. Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii49-54. doi: 10.1136/ard.2004.034165. Ann Rheum Dis. 2005. PMID: 15708937 Free PMC article. Review.
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors.
Fransen J, Antoni C, Mease PJ, Uter W, Kavanaugh A, Kalden JR, Van Riel PL. Fransen J, et al. Among authors: mease pj. Ann Rheum Dis. 2006 Oct;65(10):1373-8. doi: 10.1136/ard.2006.051706. Epub 2006 Apr 27. Ann Rheum Dis. 2006. PMID: 16644783 Free PMC article.
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial.
Gladman DD, Mease PJ, Cifaldi MA, Perdok RJ, Sasso E, Medich J. Gladman DD, et al. Among authors: mease pj. Ann Rheum Dis. 2007 Feb;66(2):163-8. doi: 10.1136/ard.2006.057901. Epub 2006 Oct 17. Ann Rheum Dis. 2007. PMID: 17046964 Free PMC article. Clinical Trial.
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.
Kavanaugh A, Krueger GG, Beutler A, Guzzo C, Zhou B, Dooley LT, Mease PJ, Gladman DD, de Vlam K, Geusens PP, Birbara C, Halter DG, Antoni C; IMPACT 2 Study Group. Kavanaugh A, et al. Among authors: mease pj. Ann Rheum Dis. 2007 Apr;66(4):498-505. doi: 10.1136/ard.2006.058339. Epub 2006 Nov 17. Ann Rheum Dis. 2007. PMID: 17114188 Free PMC article. Clinical Trial.
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial.
Tak PP, Mease PJ, Genovese MC, Kremer J, Haraoui B, Tanaka Y, Bingham CO 3rd, Ashrafzadeh A, Travers H, Safa-Leathers S, Kumar S, Dummer W. Tak PP, et al. Among authors: mease pj. Arthritis Rheum. 2012 Feb;64(2):360-70. doi: 10.1002/art.33353. Arthritis Rheum. 2012. PMID: 22389919 Free article. Clinical Trial.
425 results